Melvin L. Flowers
Known title: DirectorCIK: 0001196490
Associated companies
Transaction History
| BR | ▲ Buy | Grant | 18 | $0 | 10/5/2026 | View on chart |
| BR | ▲ Buy | Grant | 18 | $0 | 7/2/2026 | View on chart |
| BR | ▲ Buy | Grant | 16 | $0 | 4/8/2026 | View on chart |
| BR | ▲ Buy | Grant | 11 | $0 | 1/5/2026 | View on chart |
| BR | ▲ Buy | Grant | 459 | $0 | 11/13/2025 | View on chart |
| BR | ▲ Buy | Grant | 9 | $0 | 10/2/2025 | View on chart |
| BR | ▲ Buy | Grant | 8 | $0 | 7/2/2025 | View on chart |
| BR | ▲ Buy | Grant | 7 | $0 | 4/3/2025 | View on chart |
| BR | ▲ Buy | Grant | 8 | $0 | 1/3/2025 | View on chart |
| BR | ▲ Buy | Grant | 458 | $0 | 11/14/2024 | View on chart |
| BR | ▲ Buy | Grant | 6 | $0 | 10/3/2024 | View on chart |
| BR | ▲ Buy | Grant | 6 | $0 | 7/5/2024 | View on chart |
| BR | ▲ Buy | Grant | 6 | $0 | 4/5/2024 | View on chart |
| BR | ▲ Buy | Grant | 6 | $0 | 1/5/2024 | View on chart |
| BR | ▲ Buy | Grant | 538 | $0 | 11/9/2023 | View on chart |
| BR | ▲ Buy | Grant | 5 | $0 | 10/5/2023 | View on chart |
| BR | ▲ Buy | Grant | 5 | $0 | 7/6/2023 | View on chart |
| BR | ▲ Buy | Grant | 5 | $0 | 4/5/2023 | View on chart |
| BR | ▲ Buy | Grant | 5 | $0 | 1/5/2023 | View on chart |
| BR | ▲ Buy | Grant | 627 | $0 | 11/9/2022 | View on chart |
| BR | ▲ Buy | Grant | 2 | $0 | 10/5/2022 | View on chart |
| BR | ▲ Buy | Grant | 2 | $0 | 7/6/2022 | View on chart |
| BR | ▲ Buy | Grant | 1 | $0 | 4/5/2022 | View on chart |
| BR | ▲ Buy | Grant | 1 | $0 | 1/5/2022 | View on chart |
| BR | ▲ Buy | Grant | 485 | $0 | 11/18/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Broadridge (BR) Gains 14.3% as Compliance Focus Grows
Broadridge shares have risen 14.3% over the past three months, a move highlighted by recent market analysis. The stock is also drawing attention as a key player in the US compliance sector following a recent penalty involving Bank of America. This growth aligns with the company's status as a dividend growth stock, with an average analyst target price of $213.38.
Broadridge (BR) Gains 14.3% as Compliance Focus Grows. Broadridge shares have risen 14.3% over the past three months, a move highlighted by recent market analysis. The stock is also drawing attention as a key player in the US compliance sector following a recent penalty involving Bank of America. This growth aligns with the company's status as a dividend growth stock, with an average analyst target price of $213.38.